Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Miess-Tanneberg E"'
Autor:
Drube, J., Haider, R. S., Matthees, E. S. F., Reichel, M., Zeiner, J., Fritzwanker, S., Ziegler, C., Barz, S., Klement, L., Filor, J., Weitzel, V., Kliewer, A., Miess-Tanneberg, E., Kostenis, E., Schulz, S., Hoffmann, C.
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Nature Communications
Nature Communications
G protein-coupled receptors (GPCRs) activate G proteins and undergo a complex regulation by interaction with GPCR kinases (GRKs) and the formation of receptor–arrestin complexes. However, the impact of individual GRKs on arrestin binding is not cle
Autor:
Kostenis E; Molecular, Cellular, and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany. kostenis@uni-bonn.de., Gomeza J; Molecular, Cellular, and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany., Miess-Tanneberg E; Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University of Jena, 07747, Jena, Germany., Blum NK; Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University of Jena, 07747, Jena, Germany., Benkel T; Molecular, Cellular, and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.; ISAR Bioscience, Semmelweisstraße 5, 82152, Planegg, Germany., Chevigné A; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), L-4354, Esch-sur-Alzette, Luxembourg., Hoffmann C; Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany., Kolb P; Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany., Nikolaev V; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany., Waldhoer M; InterAx Biotech AG, 5234, Villigen, Switzerland.; Ikherma Consulting Ltd, Hitchin, SG4 0TY, UK., Szpakowska M; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), L-4354, Esch-sur-Alzette, Luxembourg., Inoue A; Graduate School of Pharmaceutical Science, Tohoku University, Sendai, 980-8578, Japan., Schulz S; Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University of Jena, 07747, Jena, Germany.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 30; Vol. 14 (1), pp. 7867. Date of Electronic Publication: 2023 Nov 30.
Autor:
Benkel T; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.; Research Training Group 1873, University of Bonn, 53127, Bonn, Germany., Zimmermann M; InterAx Biotech AG, 5234, Villigen, Switzerland., Zeiner J; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany., Bravo S; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany., Merten N; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany., Lim VJY; Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany., Matthees ESF; Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany., Drube J; Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany., Miess-Tanneberg E; Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University of Jena, 07747, Jena, Germany., Malan D; Institute of Physiology I, Medical Faculty, University of Bonn, 53115, Bonn, Germany., Szpakowska M; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), L-4354, Esch-sur-Alzette, Luxembourg., Monteleone S; Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany., Grimes J; Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK., Koszegi Z; Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK., Lanoiselée Y; Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK., O'Brien S; Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK., Pavlaki N; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany., Dobberstein N; InterAx Biotech AG, 5234, Villigen, Switzerland., Inoue A; Graduate School of Pharmaceutical Science, Tohoku University, Sendai, 980-8578, Japan., Nikolaev V; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany., Calebiro D; Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK., Chevigné A; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), L-4354, Esch-sur-Alzette, Luxembourg., Sasse P; Institute of Physiology I, Medical Faculty, University of Bonn, 53115, Bonn, Germany., Schulz S; Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University of Jena, 07747, Jena, Germany.; 7TM Antibodies GmbH, 07745, Jena, Germany., Hoffmann C; Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany., Kolb P; Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany., Waldhoer M; InterAx Biotech AG, 5234, Villigen, Switzerland.; Ikherma Consulting Ltd, Hitchin, SG4 0TY, UK., Simon K; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany., Gomeza J; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany., Kostenis E; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany. kostenis@uni-bonn.de.
Publikováno v:
Nature communications [Nat Commun] 2022 Nov 19; Vol. 13 (1), pp. 7109. Date of Electronic Publication: 2022 Nov 19.
Autor:
Kaufmann J; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany.; 7TM Antibodies GmbH, Jena, Germany., Blum NK; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany.; 7TM Antibodies GmbH, Jena, Germany., Nagel F; 7TM Antibodies GmbH, Jena, Germany., Schuler A; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Drube J; Institut für Molekulare Zellbiologie, CMB-Center for Molecular Biomedicine, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Degenhart C; Lead Discovery Center GmbH, Dortmund, Germany., Engel J; Lead Discovery Center GmbH, Dortmund, Germany., Eickhoff JE; Lead Discovery Center GmbH, Dortmund, Germany., Dasgupta P; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Fritzwanker S; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Guastadisegni M; Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria., Schulte C; Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, University of Wuerzburg, Wuerzburg, Germany., Miess-Tanneberg E; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Maric HM; Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, University of Wuerzburg, Wuerzburg, Germany., Spetea M; Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria., Kliewer A; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Baumann M; Lead Discovery Center GmbH, Dortmund, Germany., Klebl B; Lead Discovery Center GmbH, Dortmund, Germany., Reinscheid RK; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Hoffmann C; Institut für Molekulare Zellbiologie, CMB-Center for Molecular Biomedicine, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany., Schulz S; Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Jena, Germany. stefan.schulz@med.uni-jena.de.; 7TM Antibodies GmbH, Jena, Germany. stefan.schulz@med.uni-jena.de.
Publikováno v:
Communications biology [Commun Biol] 2022 Nov 09; Vol. 5 (1), pp. 1206. Date of Electronic Publication: 2022 Nov 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wong YW; Cardiovascular Molecular & Therapeutics Translational Research Group, Northside Clinical School of Medicine, University of Queensland, The Prince Charles Hospital, Chermside, QLD, Australia.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., Haqqani H; Cardiovascular Molecular & Therapeutics Translational Research Group, Northside Clinical School of Medicine, University of Queensland, The Prince Charles Hospital, Chermside, QLD, Australia.; Department of Cardiology, The Prince Charles Hospital, Chermside, QLD, Australia.; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia., Molenaar P; Cardiovascular Molecular & Therapeutics Translational Research Group, Northside Clinical School of Medicine, University of Queensland, The Prince Charles Hospital, Chermside, QLD, Australia. p.molenaar@uq.edu.au.; Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia. p.molenaar@uq.edu.au.
Publikováno v:
Handbook of experimental pharmacology [Handb Exp Pharmacol] 2024; Vol. 285, pp. 247-295.
Autor:
Shpakov, Alexander O.1 (AUTHOR) alex_shpakov@list.ru
Publikováno v:
International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 7, p6187. 54p.
Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways.
Autor:
Gareri, Clarice, Pfeiffer, Conrad T., Jiang, Xue, Paulo, Joao A., Gygi, Steven P., Pham, Uyen, Chundi, Anand, Wingler, Laura M., Staus, Dean P., Stepniewski, Tomasz Maciej, Selent, Jana, Lucero, Emilio Y., Grogan, Alyssa, Rajagopal, Sudarshan, Rockman, Howard A.
Publikováno v:
Science Signaling; 8/13/2024, Vol. 17 Issue 849, p1-16, 16p
Autor:
Liu, Samuel, Anderson, Preston J., Rajagopal, Sudarshan, Lefkowitz, Robert J., Rockman, Howard A.
Publikováno v:
Circulation Research; 6/21/2024, Vol. 135 Issue 1, p174-197, 24p
Autor:
Gardner, Julia, Eiger, Dylan Scott, Hicks, Chloe, Choi, Issac, Pham, Uyen, Chundi, Anand, Namjoshi, Ojas, Rajagopal, Sudarshan
Publikováno v:
Science Signaling; 2/13/2024, Vol. 17 Issue 823, p1-17, 17p